CN Patent

CN106866483A — 布瓦西坦的晶型c及其制备方法

Assigned to Chengda Pharmaceuticals Co., Ltd. · Expires 2017-06-20 · 9y expired

What this patent protects

本发明提供一种布瓦西坦的新晶型，本发明提供的新晶型有良好的稳定性、工艺可开发和易处理等有利性能，且制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

USPTO Abstract

本发明提供一种布瓦西坦的新晶型，本发明提供的新晶型有良好的稳定性、工艺可开发和易处理等有利性能，且制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN106866483A
Jurisdiction
CN
Classification
—
Expires
2017-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Chengda Pharmaceuticals Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.